Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis

Jane E Sinclair, Helen J Mayfield, Kirsty R Short, Samuel J Brown, Rajesh Puranik, Kerrie Mengersen, John CB Litt, Colleen L Lau
doi: https://doi.org/10.1101/2022.02.07.22270637

Article usage

Article usage: February 2022 to July 2025

AbstractFullPdf
Feb 202295331207
Mar 20221934154
Apr 20221601352
May 2022141128
Jun 2022133160
Jul 202283925
Aug 202265523
Sep 202264119
Oct 202257421
Nov 202268624
Dec 202250217
Jan 202329517
Feb 20233289
Mar 202353812
Apr 20232925
May 20232338
Jun 20232072
Jul 20231383
Aug 202319175
Sep 20231391
Oct 20232278
Nov 202324144
Dec 20231723
Jan 20242316
Feb 20241485
Mar 20241455
Apr 202414115
May 202419296
Jun 20242199
Jul 2024194410
Aug 202418295
Sep 20242168
Oct 202416223
Nov 20242819
Dec 202428511
Jan 2025101212
Feb 2025122812
Mar 2025215211
Apr 2025231823
May 2025482620
Jun 2025352621
Jul 2025100
Back to top
Posted February 08, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Quantifying the risks versus benefits of the Pfizer COVID-19 vaccine in Australia: a Bayesian network analysis
Jane E Sinclair, Helen J Mayfield, Kirsty R Short, Samuel J Brown, Rajesh Puranik, Kerrie Mengersen, John CB Litt, Colleen L Lau
medRxiv 2022.02.07.22270637; doi: https://doi.org/10.1101/2022.02.07.22270637
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area